MORRISTOWN, N.J., May 30, 2012 /PRNewswire/ -- Actavis Group, an international generic pharmaceuticals company, today announced that it received US FDA approval of Nifedipine Extended-Release

MORRISTOWN, N.J., May 18, 2012 /PRNewswire/ -- Actavis Group, an international generic pharmaceuticals company, today announced that it received US FDA approval of Ropinirole Extended-Release

PARSIPPANY, N.J., May 9, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc.

PARSIPPANY, N.J., April 27, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc.

SYDNEY and BEDMINSTER, N.J., April 26, 2012 /PRNewswire/ -- QRxPharma (ASX: QRX and OTCQX: QRXPY) is pleased to report that its US commercialisation partner for MoxDuo IR, Actavis, is to be